Cargando…

Prognosis and treatment effects of HIV-associated talaromycosis in a real-world patient cohort

Talaromycosis is a leading cause of AIDS-associated opportunistic infections and death in Southeast Asia. We have recently shown in the Itraconazole versus Amphotericin for Talaromycosis (IVAP) trial that induction therapy with amphotericin B reduced mortality over 24 weeks, but not during the first...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klus, Jonathan, Ly, Vo Trieu, Chan, Cliburn, Le, Thuy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023982/ https://www.ncbi.nlm.nih.gov/pubmed/33644813 http://dx.doi.org/10.1093/mmy/myab005

Ejemplares similares

622. Development of Interferon-Gamma Release Assays for Diagnosing Latent Talaromycosis
por: Xu, Helen, et al.
Publicado: (2023)

Cost-Effectiveness of Amphotericin B Deoxycholate Versus Itraconazole for Induction Therapy of Talaromycosis in Human Immunodeficiency Virus–Infected Adults in Vietnam
por: Buchanan, James, et al.
Publicado: (2021)

Disseminated talaromycosis in an HIV-infected patient
por: Chang, Chee Yik, et al.
Publicado: (2021)

Pulmonary Talaromycosis: A Window into the Immunopathogenesis of an Endemic Mycosis
por: Narayanasamy, Shanti, et al.
Publicado: (2021)

Non-HIV talaromycosis: Radiological and clinical analysis
por: Li, Xinchun, et al.
Publicado: (2020)

Superiority of a Novel Mp1p Antigen Detection Enzyme Immunoassay Compared to Standard BACTEC Blood Culture in the Diagnosis of Talaromycosis
por: Thu, Nguyen T M, et al.
Publicado: (2020)

Advances in diagnosis and treatment of talaromycosis in patients with AIDS
por: Guo, Pengle, et al.
Publicado: (2022)

Successful treatment of AIDS-associated talaromycosis with low-dose itraconazole
por: Pudjiati, Satiti Retno, et al.
Publicado: (2020)

Colesional cutaneous talaromycosis (penicilliosis) and Kaposi sarcoma in an HIV‐infected patient
por: Lai, Shau‐Kong, et al.
Publicado: (2021)

Clinical Characteristics Associated with Poor Prognosis of Acquired Immunodeficiency Syndrome Patients Complicated with Disseminated Talaromycosis marneffei
por: Wu, Lianpeng, et al.
Publicado: (2023)

S2.2c Talaromycosis in HIV-negative patients: challenges and counter-measures
por: Cao, Cunwei
Publicado: (2022)

Drug-related talaromycosis: A case report
por: Lu, Yongsheng, et al.
Publicado: (2020)

Efficacy and Safety of Voriconazole Versus Amphotericin B Deoxycholate Induction Treatment for HIV-Associated Talaromycosis: A Prospective Multicenter Cohort Study in China
por: Zhou, Yihong, et al.
Publicado: (2022)

Imported Talaromycosis in Oman in Advanced HIV: A Diagnostic Challenge Outside the Endemic Areas
por: Mohsin, Jalila, et al.
Publicado: (2017)

Is stopping secondary prophylaxis safe in HIV‐positive talaromycosis patients? Experience from Myanmar
por: Tun, N, et al.
Publicado: (2020)

Talaromycosis in a Patient on Nintedanib for Interstitial Lung Disease
por: Madgula, Anantha Sriharsha, et al.
Publicado: (2020)

An Overview of Diagnostic and Management Strategies for Talaromycosis, an Underrated Disease
por: Zaongo, Silvere D., et al.
Publicado: (2023)

Clinical performance of metagenomic next-generation sequencing for the rapid diagnosis of talaromycosis in HIV-infected patients
por: Mao, Yuhuan, et al.
Publicado: (2022)

Clinical features of HIV positive talaromycosis marneffei patients and development of a risk prediction model
por: Cen, Jiemei, et al.
Publicado: (2023)

Talaromycosis (Penicilliosis): A Rare, Opportunistic Systemic Fungal Infection
por: Gorai, Surajit, et al.
Publicado: (2019)

Talaromycosis in a Lung Cancer Patient: A Rare Case
por: Ching-López, Rosario, et al.
Publicado: (2020)

Population pharmacokinetics of voriconazole and initial dosage optimization in patients with talaromycosis
por: Jiang, Zhiwen, et al.
Publicado: (2022)

Multicentre derivation and validation of a prognostic scoring system for mortality assessment in HIV‐infected patients with talaromycosis
por: Qin, Yuanyuan, et al.
Publicado: (2020)

Metagenomic next-generation sequencing for the early diagnosis of talaromycosis in HIV-uninfected patients: five cases report
por: Chen, Qiuhua, et al.
Publicado: (2021)

Environmental Risk Factors for Talaromycosis Hospitalizations of HIV-Infected Patients in Guangzhou, China: Case Crossover Study
por: Wang, Yaping, et al.
Publicado: (2021)

Rare incidence of non-secretory myeloma with talaromycosis: a case report
por: Qin, Haiting, et al.
Publicado: (2021)

Clinical features of patients with talaromycosis marneffei and microbiological characteristics of the causative strains
por: Peng, Lei, et al.
Publicado: (2022)

P403 Metagenomic sequencing as an effective diagnostic tool for Talaromycosis in HIV-negative patients: A retrospective study
por: Liang, Tianwei, et al.
Publicado: (2022)

1390. Talaromycosis: Differences between Patients with The Anti-interferon-γ Autoantibody and People Living with HIV/AIDS (PLWHA)
por: Krasaewes, Kawisara, et al.
Publicado: (2023)

Case Report: Metagenomic Next-Generation Sequencing in Diagnosis of Talaromycosis of an Immunocompetent Patient
por: Shi, Jiejun, et al.
Publicado: (2021)

Analysis of clinical characteristics and prognosis of talaromycosis (with or without human immunodeficiency virus) from a non-endemic area: a retrospective study
por: Shen, Qian, et al.
Publicado: (2021)

Disseminated talaromycosis complicated by recurrent gastrointestinal bleeding and hemorrhagic shock: a case report
por: Cui, Xiaoya, et al.
Publicado: (2022)

Severe anemia, severe leukopenia, and severe thrombocytopenia of amphotericin B deoxycholate-based induction therapy in patients with HIV-associated talaromycosis: a subgroup analysis of a prospective multicenter cohort study
por: Zhou, Yihong, et al.
Publicado: (2023)

A case report of Talaromyces marneffei Oro-pharyngo-laryngitis: a rare manifestation of Talaromycosis
por: Wongkamhla, Thanyarak, et al.
Publicado: (2019)

Talaromycosis-Associated Secondary Hemophagocytic Lymphohistiocytosis in Nine Human Immunodeficiency Virus-Negative Patients: A Multicenter Retrospective Study
por: Pan, Mianluan, et al.
Publicado: (2019)

Central Nervous System Infection with Other Endemic Mycoses: Rare Manifestation of Blastomycosis, Paracoccidioidomycosis, Talaromycosis, and Sporotrichosis
por: Kauffman, Carol A.
Publicado: (2019)

Comparison of pleural effusion features and biomarkers between talaromycosis and tuberculosis in non-human immunodeficiency virus-infected patients
por: Qiu, Ye, et al.
Publicado: (2019)

Brain Nocardiosis and Pulmonary Talaromycosis Infection in a Patient with Anti-IFN-γ Autoantibodies: A Case Report
por: Wu, Siyao, et al.
Publicado: (2023)

The Association of TLR2, TLR3, and TLR9 Gene Polymorphisms With Susceptibility to Talaromycosis Among Han Chinese AIDS Patients in Guangdong
por: Wang, Min, et al.
Publicado: (2021)

The delayed clearance of Talaromyces marneffei in blood culture may be associated with higher MIC of voriconazole after antifungal therapy among AIDS patients with talaromycosis
por: Guo, Pengle, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3aid4unsu3op6dk1va6d9blni3